This protocol is judged by an institutional assessment board, an independent team that evaluations any medical trials involving individuals. If a study consists of a Agenda I drug, as soon as the board approves the protocol as moral, the researchers really need to submit an application for an investigational new drug (IND) variety with the FDA.cop